All posts by: Michael Zand

About Michael Zand

HSU Undergraduate Students Get Hands on Experience in Editing Genomes Using CRISPR – Redheaded Blackbelt

Continue reading

2017-11-20 NEWS

Redheaded Blackbelt

HSU Undergraduate Students Get Hands on Experience in Editing Genomes Using CRISPR
Redheaded Blackbelt
Using the CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated gene 9)-based techniques, students in Biology Professor John Steele’s classes and labs have been editing the genetic material of cells, inserting …

Continue reading

2017-11-20 NEWS

Genetic Literacy Project

New FDA framework points to boost for cell and gene therapies
BioPharma Dive
After decades of research, cell and gene therapies are finally emerging onto the marketplace and showing potential for regenerative medicine in serious conditions. Two cell-based gene therapies, Novartis AG’s Kymriah (tisagenlecleucel) and Gilead …
BioNews – FDA to speed up gene therapy and regenerative …BioNews
Gene therapy boost: FDA positions for faster reviews of new treatmentsGenetic Literacy Project
FDA Issues Final and Draft Regenerative Medicine Guidance …Genetic Engineering & Biotechnology News (blog)
The Pharma Letter
all 9 news articles »
Continue reading

2017-11-20 NEWS

Futurism

Scientists Engineer Nonimmune Cells That Kill Cancer Upon Contact
Futurism
In the continuous search for potentially cancer-curing treatments, researchers have turned to engineering cells. They’ve found that modifying immune cells so that they recognize cancer cells, a technique called chimeric antigen receptor (CAR) T-cell

and more »

Continue reading

2017-11-20 NEWS

Stanford Medical Center Report

Clinical trial suggests new cell therapy for relapsed leukemia patients
Stanford Medical Center Report
The therapy is similar to but distinct from CD19-targeted chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, in which a patient’s T cells are genetically modified to target a molecule called CD19 on the surface of the cancer cells. This

and more »

Continue reading

2017-11-20 NEWS

Curetoday.com

Immunotherapy Techniques Are Being Explored in Gliomas
Curetoday.com
Many of these approaches are, however, being studied both in labs and in clinical trials, and the growing understanding of what works, what doesn’t and why provides a basis for hope that immunotherapy will eventually play a role in the treatment of

Continue reading

2017-11-20 NEWS

San Marcos Corridor News

Modified blood stem cells reverse type 1 diabetes in mice
Diabetes.co.uk
A new landmark study shows that gene-editing blood stem cells, or treating them with a triad of immune cell therapies, can reverse type 1 diabetes in mice. Edited blood stem cells may be used to re-educate the immune system’s T cells, thereby curbing …
Confronting unproven stem cell treatments in Australia: The new regulationBioNews
FDA Warns About Unapproved, Unproven Stem Cell Therapies, Suggests Confirmation On All TreatmentsSan Marcos Corridor News

all 4 news articles »